1 active not recruiting. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Active not recruiting 1 |
Follow Liver Biopsy: new trials by email Literature Review of Liver Biopsy trials Research Report on Liver Biopsy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase 3 Study to Evaluate the Efficacy and Safety of MGL-3196 (Resmetirom) in Patients With NASH and Fibrosis MGL-3196, Placebo, Liver Biopsy - NASH - Nonalcoholic Steatohepatitis | Phase 3 | Active not recruiting | Madrigal Pharmaceuticals, Inc. | 1759 | 2019-03-28 | 2026-06-01 |
Non-alcoholic Fatty Liver Disease (1)
Madrigal Pharmaceuticals, Inc. (1)
Australia (1) · Austria (1) · Belgium (1) · Canada (1) · France (1) · Germany (1) · Hungary (1) · Israel (1) · Italy (1) · Mexico (1) · Poland (1) · Puerto Rico (1) · Spain (1) · Switzerland (1) · United Kingdom (1)
Tom Hare (1)
PMID 33860116, PMID 37786277, PMID 38324483, PMID 39250515, PMID 41127972, PMID 41895606